Second Opinion can be used to detect several dental conditions, including caries, discrepancies at the margin of existing restorations, tooth tartar and periapical radiolucency.
Pearl said the software exceeded the FDA’s efficacy requirements in four separate clinical studies, accurately identifying 36 percent more lesions than X-rays without AI assistance.
The software also has clearance in Europe, Canada, United Arab Emirates, Australia and New Zealand.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
